SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-24-000021
Filing Date
2024-03-29
Accepted
2024-03-29 08:35:55
Documents
19
Period of Report
2024-03-29
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K angn-20240329.htm   iXBRL 8-K 23532
2 EX-99.1 a2024-03x29xxeltxxx4qfy2.htm EX-99.1 15415
6 a2024-03x29xxeltxxx4qfy2001.jpg GRAPHIC 214214
7 a2024-03x29xxeltxxx4qfy2002.jpg GRAPHIC 203318
8 a2024-03x29xxeltxxx4qfy2003.jpg GRAPHIC 120623
9 a2024-03x29xxeltxxx4qfy2004.jpg GRAPHIC 309598
10 a2024-03x29xxeltxxx4qfy2005.jpg GRAPHIC 218382
  Complete submission text file 0001601485-24-000021.txt   1643734

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20240329.xsd EX-101.SCH 1989
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20240329_lab.xml EX-101.LAB 22786
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20240329_pre.xml EX-101.PRE 13130
22 EXTRACTED XBRL INSTANCE DOCUMENT angn-20240329_htm.xml XML 2816
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 24802127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)